The largest database of trusted experimental protocols

Stata software package version 13

Manufactured by StataCorp
Sourced in United States

Stata® Software package, Version 13 is a powerful statistical software used for data analysis, data management, and graphics. It provides a wide range of statistical tools and techniques for researchers, analysts, and professionals working in various fields. The software is designed to handle complex data, perform advanced statistical modeling, and generate high-quality visualizations.

Automatically generated - may contain errors

7 protocols using stata software package version 13

1

Descriptive Statistical Analysis in Stata

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data were entered into Microsoft Excel 2007 sheets, double checked against written data collection forms and then transferred to Stata® Software package, Version 13 (Stata Corporation, College Station, Texas 77,845 USA, stata@stata.com) for analysis. Descriptive statistics were generated.
+ Open protocol
+ Expand
2

Data Analysis of Biomedical Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data was entered into excel sheets (Microsoft Office, 2007) and validated by checking all entries against all of the original data collection forms. Then data was exported to Stata® Software package, Version 13 (Stata Corporation, College Station, Texas 77845 USA, stata@stata.com) for analysis. Spearman’s rank correlation coefficient was calculated to assess the relationship between pairs of continuous groups of variables which were not normally distributed. The Wilcoxon rank sum test was used to establish if there were differences in the number of lesions in animals between two groups or predilection sites. Mid p-exact tests were conducted using the rate2by2.test function as implemented in the epitools package in R-software to establish the significance of differences between proportions. Only p-values of less than 0.05 were considered statistically significant.
+ Open protocol
+ Expand
3

Genetic Associations with Second Primary Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The main findings were reported in a tabular synthesis, separately for each SNP, and the qualitative synthesis reported possible associations of each SNP with the SPC risk. Meta-analysis was performed considering different study designs, and the SNPs studied reported in each study. When at least two studies on the same SNP were available and evaluated the same genotype model, the data were pooled in a random-effect meta-analyses [20 ]. Effect size were expressed as hazard ratios (HR) or odds ratios (OR) with the corresponding 95% confidence intervals (CI), as appropriate. We stratified the analyses according to the site of SPC. The heterogeneity between studies was assessed using the χ2-based Q-statistics and the I2 statistics [21 ]. The heterogeneity was considered low if the I2 value was < 25%. P-values of less than 0.05 were considered statistically significant. To assess the presence of publication bias (where appropriate), we conducted Egger’s asymmetry test (level of significance p < 0.05) for the SNPs with at least three pooled studies [22 (link)]. Statistical analyses were performed using the Stata software package version 13 (StataCorp. College Station. Texas).
+ Open protocol
+ Expand
4

Survival Outcomes in Discovered vs. Undiscovered Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Overall survival (OS), cause-specific survival (CSS), and disease-free survival (DFS) between the discovered and never-discovered patient cohorts were compared using Kaplan-Meier estimates and the log-rank test for equality of survival curves. A matching variable was used in the analysis to account for matching based on age, clinical nodal stage, and treatment. Matched-pair analysis was further compared using the stratified Cox regression model. Analysis was completed for date of diagnosis to date of most recent oncologic follow-up, with death and first recurrence as censoring variables. Death was subdivided into death secondary to disease or due to other causes. Patient characteristics that were not matched were evaluated by the χ2 test. SPSS software package version 21.0 (SPSS Inc, Chicago, Illinois) and STATA software package version 13.0 (StataCorp, College Station, Texas) were used for statistical computation.
+ Open protocol
+ Expand
5

Prognostic Value of SIX Genes in NSCLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Meta-Analysis of Observational Studies served as guidelines applied for statistical analysis [20 (link)]. HRs and 95 % CIs were calculated to represent the prognosis of NSCLC with expression of the SIX family genes. Clinicopathological parameters included histological type, lymph node metastasis (LNM), and TNM stage. Heterogeneity of the ORs and HRs was assessed and quantified using Cochrane Q and I2 test. Random-effect model was employed if there was heterogeneity between studies (p < 0.05 or I2 > 50 %). Otherwise, fixed-effect model was applied. Begg’s rank correlation method and Egger’s weighted regression method were used to screen for potential publication bias. All p values were two tailed, and all analyses were accomplished using STATA software package (version 13.0) (Stata Corp LP, College Station, TX, USA). We selected the representative datasets, GSE19188, GSE19804, and GSE32863 to analyze the significance of SIX expression in clinicopathological features of NSCLC. The bar graphs were printed using GraphPad Prism 5.0 software. Unpaired t test was used to determine differences between groups.
+ Open protocol
+ Expand
6

Comparative Analysis of ICPC-2 Diagnoses in CFS/ME

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each ICPC-2 diagnosis, the proportion of children registered was calculated in each group. Proportions were adjusted for sex and age by direct standardization, using the CSF/ME group as the standard population. Non-overlapping confidence intervals (99 %) show statistically significant differences in proportions. With the exception of the ICPC-2 codes for diabetes (T89/T90), only ICPC-2 codes registered for more than 50 patients with CFS/ME were included to the analyses.
The Stata software package, Version 13.1 (StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX, USA: StataCorp LP) was used for data analysis.
+ Open protocol
+ Expand
7

Methylation Patterns in TCDD Exposure

Check if the same lab product or an alternative is used in the 5 most similar protocols
Differences in age, anthropometric and semen parameters were evaluated using a two-sided Wilcoxon rank-sum test, Stata software package version 13.1 (StataCorp LP, USA). Differences in the average and distribution of methylation across all CpG sites between the highest and lowest TCDD concentrations were assessed by t-test and Kolmogorov-Smirnov (KS) tests, respectively. For enrichment analyses, 2 × 2 contingency tables were created and Fishers Exact test was used to determine significant enrichment of genomic loci of interest between TCDD groups. KS and Fishers Exact tests were performed using scipy package (v0.18.0) [39 ] and statistical significance was determined using a threshold of p < 0.05.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!